Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer
Clinical trial NCT05398861 · RECRUITING
Trial details
- NCT number
- NCT05398861
- Sponsor
- Henan Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-19
- Primary completion
- 2026-12-30
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.